Review Article

An Overview of Systematic Reviews of Randomized Controlled Trials on Acupuncture Treating Migraine

Table 1

Basic information of included studies.

Study IDParticipantAcute or preventive treatmentInterventionControlOutcome measuresDesignTrials (participants)Risk of bias assessment tool

Linde et al. [14]Migraine patientsNRAcupuncture①②③At least one clinical outcome related to headacheRCT26 (1151)Risk of bias approach for Cochrane reviews
Linde et al. [7]Episodic migraine patientsPreventive treatmentAcupuncture with or without manual or electrical stimulation①②③Headache frequency, response, and quality of lifeRCT22 (4985)α
Chen et al. [15]Migraine patientsNRAcupunctureRCT18 (1730)β
Chen [16]Migraine patientsNRAcupunctureAcupuncture not according to meridians;①②③ and other treatmentsRCT18 (1672)α
Chu et al. [17]Migraine patientsNRAcupuncture②③NRRCT24 (2397)α
Cui et al. [18]Migraine patientsNRAcupuncture with or without electrical stimulation②③ and other treatments.RCT15 (1288)α
Dai and Lin [19]Migraine patientsNRAcupunctureNRNRRCT2 (140)β
Gao et al. [20]NRNRAcupunctureRCT12 (1744)β
Yang et al. [21]Migraine patientsNRAcupunctureAt least one clinical outcome related to headacheRCT10 (997)α
Zheng and Hai [22]Migraine patientsNRAcupunctureNRNRRCT33 (3593)α
Zhao [23]Menstrual migraine patientsNRAcupuncture with or without other treatments②③ and other treatments.ⒶⒷⒸ, pain index, pain time, symptom score, and biochemical indexes.RCT18 (1268)α
Pu [24]Migraine patientsPreventive treatmentAcupunctureⒶⒷⒸ, migraine days, migraine frequency, times of analgesics used, and follow-up rate.RCT7 (1285)α
Pu et al. [25]Migraine patientsAcute treatmentAcupunctureRCT5 (618)α
Song et al. [26]Migraine patientsPreventive treatmentAcupuncture with or without electrical stimulation or placebo③ with or without placeboⒷ, pain days, and other outcome.RCT18 (1470)α
Yang et al. [27]Migraine patientsNRAcupunctureⒷⒸ; pain indexRCT10 (893)α

NR: not reported in inclusion criteria; ①: no acupuncture; ②: sham acupuncture; ③: drug treatment; Ⓐ: visual analogue scale (VAS) pain score; Ⓑ: efficacy: Ⓒ: adverse events; α: Cochrane risk of bias assessment tool [28]; β: Jadad scale [29].